These updates unsettled investor confidence in the stock. Body & Bath Works’ competitor, Ulta Beauty, Inc. (ULTA), experienced marginal gains over the past year and dipped 17.9% in 2024 ...

Shares of personal care and home fragrance retailer Bath & Body Works ... overall performance remained weak. The shares closed the day at $35.86, down 12.8% from previous close. The stock market ...

What a brutal six months it’s been for Bath and Body Works. The stock has dropped 27.9% and now trades at $27.80, rattling ...

Ike Boruchow has given his Hold rating due to a combination of factors affecting Bath & Body Works, including disappointing performance ... a Hold rating on the stock with a $39.00 price target.

Analyst Alexandra Straton from Morgan Stanley maintained a Buy rating on the stock and has a $56.00 price target. Alexandra Straton’s rating is based on Bath & Body Works’ ability to navigate ...

After a 22% decline year-to-date, at the current price of around $33 per share, we believe Bath & Body Works stock (NYSE: BBWI), the largest specialty home fragrance & body care product retailer ...

3Q24 sales performance tracked better than my FY23 estimate of -4% growth previously. Even better, gross margin came in at 43.7%, expanding by 140 bps, beating even consensus estimate of 42.5%.

Analysts on Wall Street project that Bath & Body ... of a stock. While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly ...

Here is some historical data on the prior post-earnings performance of Bath & Body Works stock in relation to the stock performance of peers that released earnings just before Bath & Body Works.

"We are pleased to have delivered better-than-anticipated bottom-line performance ... Action: Bath & Body Works has a 52-week high of $82 and a 52-week low of $25.75. The stock was up 22.4% ...